LakeShore Biopharma Co., Ltd
LakeShore Biopharma Co., Ltd (LSB) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
lsb · pe ratio · data through Mar 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for LakeShore Biopharma Co., Ltd (LSB) measures how much investors pay for each dollar of the company's trailing earnings. LSB's current PE ratio of N/A is calculated by dividing its stock price of $0.63 by its TTM earnings per share of -$0.94.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-03-31
PE Ratio History
2021 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
LakeShore Biopharma Co., LtdYou LSB | $26M | N/A | — | -$0.94 |
 Allakos Inc. ALLK | $30M | N/A | — | -$1.30 |
 AnPac Bio-Medical Science Co., Ltd. ANPC | $27M | N/A | — | -$54.18 |
 Elevation Oncology, Inc. ELEV | $22M | N/A | — | -$0.78 |
 Freeline Therapeutics Holdings plc FRLN | $28M | N/A | — | -$22.52 |
 Gemini Therapeutics, Inc. GMTX | $25M | N/A | — | — |
 Invacare Corporation IVC | $25M | N/A | — | -$2.77 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-03-31Latest FY2025 | — | $-0.94 | — | |
2024-03-31 FY2024 | — | $-4.05 | — | |
2023-03-31 FY2023 | — | $-1.88 | — | |
2022-03-31 FY2022 | — | $-8.02 | — | |
2021-03-31 FY2021 | — | $-6.67 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for LakeShore Biopharma Co., Ltd (LSB) measures how much investors pay for each dollar of the company's trailing earnings. LSB's current PE ratio of N/A is calculated by dividing its stock price of $0.63 by its TTM earnings per share of -$0.94.
Frequently asked questions
LSB pe ratio · 6 questionsLSB's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.63 and TTM EPS of -$0.94. Data sourced from Financial Modeling Prep via LSB's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · LakeShore Biopharma Co., Ltd SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09